Zevra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZVRA and other ETFs, options, and stocks.About ZVRA
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia.
CEONeil F. McFarlane
CEONeil F. McFarlane
Employees59
Employees59
HeadquartersCelebration, Florida
HeadquartersCelebration, Florida
Founded2006
Founded2006
Employees59
Employees59
ZVRA Key Statistics
Market cap486.38M
Market cap486.38M
Price-Earnings ratio-4.71
Price-Earnings ratio-4.71
Dividend yield—
Dividend yield—
Average volume725.57K
Average volume725.57K
High today$8.92
High today$8.92
Low today$8.51
Low today$8.51
Open price$8.57
Open price$8.57
Volume552.35K
Volume552.35K
52 Week high$9.76
52 Week high$9.76
52 Week low$4.20
52 Week low$4.20
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ZVRA. This list is generated using Robinhood data, and it’s not a recommendation.